216 related articles for article (PubMed ID: 19680727)
1. Use of percutaneous radiofrequency ablation in pulmonary metastases from renal cell carcinoma.
Shu Yan Huo A; Lawson Morris D; King J; Glenn D
Ann Surg Oncol; 2009 Nov; 16(11):3169-75. PubMed ID: 19680727
[TBL] [Abstract][Full Text] [Related]
2. [Radiofrequency ablation (RFA) of lung metastases from colorectal cancer (CRC)-one-year follow-up].
Steinke K; King J; Glenn D; Morris DL
Radiologe; 2004 Jul; 44(7):687-92. PubMed ID: 15232689
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
[TBL] [Abstract][Full Text] [Related]
4. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
Forauer AR; Dewey BJ; Seigne JD
Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
[TBL] [Abstract][Full Text] [Related]
5. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease.
Xu L; Rong Y; Wang W; Lian H; Gan W; Yan X; Li X; Guo H
World J Surg Oncol; 2016 Jul; 14(1):193. PubMed ID: 27460786
[TBL] [Abstract][Full Text] [Related]
7. [Percutaneous CT-guided radiofrequency ablation for small renal masses : A retrospective, single center data analysis].
Heißler O; Seklehner S; Fellner H; Engelhardt PF; Chemelli A; Riedl C
Urologe A; 2018 Jul; 57(7):828-835. PubMed ID: 29797025
[TBL] [Abstract][Full Text] [Related]
8. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
[TBL] [Abstract][Full Text] [Related]
9. Comparative survival analysis in patients with pulmonary metastases from nasopharyngeal carcinoma treated with radiofrequency ablation.
Pan CC; Wu PH; Yu JR; Li W; Huang ZL; Wang JP; Zhao M
Eur J Radiol; 2012 Apr; 81(4):e473-7. PubMed ID: 21700408
[TBL] [Abstract][Full Text] [Related]
10. A novel strategy for treatment of metastatic pulmonary tumors: radiofrequency ablation in conjunction with surgery.
Sano Y; Kanazawa S; Mimura H; Gobara H; Hiraki T; Fujiwara H; Yamane M; Toyooka S; Oto T; Date H
J Thorac Oncol; 2008 Mar; 3(3):283-8. PubMed ID: 18317072
[TBL] [Abstract][Full Text] [Related]
11. Improved outcome with combined US/CT guidance as compared to US guidance in percutaneous radiofrequency ablation of small renal masses.
Andersson M; Hashimi F; Lyrdal D; Lundstam S; Hellström M
Acta Radiol; 2015 Dec; 56(12):1519-26. PubMed ID: 25414370
[TBL] [Abstract][Full Text] [Related]
12. [Pulmonary resections for metastatic renal cell carcinoma in Iceland].
Oddsson SJ; Isaksson HJ; Jonsson E; Einarsson GV; Gudbjartsson T
Laeknabladid; 2008 May; 94(5):377-81. PubMed ID: 18460734
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies: a large single-center experience.
Sano Y; Kanazawa S; Gobara H; Mukai T; Hiraki T; Hase S; Toyooka S; Aoe M; Date H
Cancer; 2007 Apr; 109(7):1397-405. PubMed ID: 17315166
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous radiofrequency ablation for unresectable pulmonary metastases from renal cell carcinoma.
Soga N; Yamakado K; Gohara H; Takaki H; Hiraki T; Yamada T; Arima K; Takeda K; Kanazawa S; Sugimura Y
BJU Int; 2009 Sep; 104(6):790-4. PubMed ID: 19338555
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous CT-Guided Radiofrequency Ablation of Solitary Small Renal Masses: A Single Center Experience.
Pieper CC; Fischer S; Strunk H; Meyer C; Thomas D; Willinek WA; Hauser S; Nadal J; Schild H; Wilhelm K
Rofo; 2015 Jul; 187(7):577-83. PubMed ID: 25962750
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous regression of pulmonary and adrenal metastases following percutaneous radiofrequency ablation of a recurrent renal cell carcinoma.
Kim H; Park BK; Kim CK
Korean J Radiol; 2008; 9(5):470-2. PubMed ID: 18838859
[TBL] [Abstract][Full Text] [Related]
17. General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results.
Gupta A; Raman JD; Leveillee RJ; Wingo MS; Zeltser IS; Lotan Y; Trimmer C; Stern JM; Cadeddu JA
J Endourol; 2009 Jul; 23(7):1099-105. PubMed ID: 19530948
[TBL] [Abstract][Full Text] [Related]
18. [Percutaneous thermoablation of pulmonary metastases. Experience with the application of laser-induced thermotherapy (LITT) and radiofrequency ablation (RFA), and a literature review].
Vogl TJ; Straub R; Lehnert T; Eichler K; Lüder-Lühr T; Peters J; Zangos S; Söllner O; Mack M
Rofo; 2004 Nov; 176(11):1658-66. PubMed ID: 15497085
[TBL] [Abstract][Full Text] [Related]
19. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas.
McClure TD; Chow DS; Tan N; Sayre JA; Pantuck AJ; Raman SS
J Vasc Interv Radiol; 2014 Nov; 25(11):1682-8; quiz 1689. PubMed ID: 25081202
[TBL] [Abstract][Full Text] [Related]
20. Adrenal neoplasms: CT-guided radiofrequency ablation--preliminary results.
Mayo-Smith WW; Dupuy DE
Radiology; 2004 Apr; 231(1):225-30. PubMed ID: 14990812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
